PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmacology and Toxicology, College of Pharmacy, The University of Arizona, Tucson, AZ, 85721, USA.\', \'Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, 33612, USA.\', \'Institute for Antiviral Research, Utah State University, Logan, UT, 84322, USA.\', \'Department of Animal, Dairy and Veterinary Sciences, Utah State University, Logan, UT, 84322, USA.\', \'Department of Chemistry and Biochemistry, The University of Arizona, Tucson, AZ, 85721, USA.\', \'Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, 33612, USA. ychen1@usf.edu.\', \'Department of Pharmacology and Toxicology, College of Pharmacy, The University of Arizona, Tucson, AZ, 85721, USA. junwang@pharmacy.arizona.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41422-020-0356-z
?:doi
?:hasPublicationType
?:journal
  • Cell research
is ?:pmid of
?:pmid
?:pmid
  • 32541865
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.839
?:rankingScore_hIndex
  • 133
?:title
  • Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all